tiprankstipranks
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
US Market
ELDN
Eledon Pharmaceuticals
RESEARCH TOOLSreports

Eledon Pharmaceuticals (ELDN) Financial Statements

Compare
1,017 Followers

Eledon Pharmaceuticals Financial Overview

Eledon Pharmaceuticals's market cap is currently $221.49M. The company's EPS TTM is $-0.125; its P/E ratio is -2.71; Eledon Pharmaceuticals is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -359.00K$ -374.00K$ -373.00K$ -195.00K
Operating Income$ -83.25M$ -70.58M$ -43.00M$ -39.78M$ -36.87M
EBITDA$ -83.25M$ -35.39M$ -116.16M$ -87.59M$ -36.66M
Net Income$ -45.62M$ -36.18M$ -116.54M$ -87.97M$ -34.51M
Balance Sheet
Cash & Short-Term Investments$ 133.34M$ 140.18M$ 51.10M$ 56.41M$ 84.83M
Total Assets$ 237.60M$ 177.41M$ 89.07M$ 92.79M$ 170.55M
Total Debt$ 641.00K$ 954.00K$ 383.00K$ 746.00K$ 769.00K
Net Debt$ -22.17M$ -19.59M$ -4.23M$ -55.66M$ -84.06M
Total Liabilities$ 100.82M$ 59.27M$ 81.86M$ 8.61M$ 6.55M
Stockholders' Equity$ 136.78M$ 118.14M$ 7.21M$ 84.18M$ 164.00M
Cash Flow
Free Cash Flow$ -62.34M$ -47.27M$ -39.53M$ -28.42M$ -28.91M
Operating Cash Flow$ -62.34M$ -47.27M$ -39.53M$ -28.42M$ -28.91M
Investing Cash Flow$ 10.79M$ -70.31M$ -45.29M$ 0.00$ 0.00
Financing Cash Flow$ 53.81M$ 133.52M$ 33.02M$ 0.00$ -449.00K
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History

Income Statement >

Eledon Pharmaceuticals Debt to Assets

Balance Sheet >

Eledon Pharmaceuticals Cash Flow

Cash Flow >

Eledon Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >